Los Angeles Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,250
| Closed | -$642K | – | 1323 |
|
|
2022
Q3 | $642K | Sell |
4,250
-661
| -13% | -$99.9K | ﹤0.01% | 848 |
|
|
2022
Q2 | $716K | Sell |
4,911
-1,697
| -26% | -$247K | ﹤0.01% | 835 |
|
|
2022
Q1 | $784K | Buy |
6,608
+40
| +0.6% | +$4.75K | ﹤0.01% | 861 |
|
|
2021
Q4 | $905K | Buy |
+6,568
| New | +$905K | ﹤0.01% | 759 |
|
|
2021
Q2 | – | Sell |
-6,750
| Closed | -$461K | – | 1757 |
|
|
2021
Q1 | $461K | Sell |
6,750
-5,655
| -46% | -$386K | ﹤0.01% | 1251 |
|
|
2020
Q4 | $1.06M | Sell |
12,405
-15
| -0.1% | -$1.29K | ﹤0.01% | 923 |
|
|
2020
Q3 | $807K | Buy |
12,420
+1,255
| +11% | +$81.5K | ﹤0.01% | 905 |
|
|
2020
Q2 | $816K | Buy |
11,165
+2,285
| +26% | +$167K | ﹤0.01% | 923 |
|
|
2020
Q1 | $302K | Hold |
8,880
| – | – | ﹤0.01% | 1052 |
|
|
2019
Q4 | $483K | Buy |
8,880
+1,030
| +13% | +$56K | ﹤0.01% | 1029 |
|
|
2019
Q3 | $328K | Buy |
+7,850
| New | +$328K | ﹤0.01% | 1104 |
|